Request appointment
1275 York AvenueNew York, NY 10065
Overview of Dr. Trippett
Dr. Tanya Trippett is a pediatric hematologist/oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and NYC Health + Hospitals / Bellevue. She received her medical degree from Duke University School of Medicine and has been in practice 41 years. She is one of 107 doctors at Memorial Sloan Kettering Cancer Center and one of 14 doctors at NYC Health + Hospitals / Bellevue who specialize in Pediatric Hematology & Oncology. She also speaks multiple languages, including French. She has more than 70 publications and over 500 citings.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1988 - 1991
Duke University HospitalResidency, Pediatrics, 1985 - 1988
Duke University School of MedicineClass of 1985
Certifications & Licensure
NJ State Medical License 2023 - 2027
NY State Medical License 1995 - 2026
NC State Medical License 1987 - 1998
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2014
- New York Magazine: Top Doctors Castle Connolly, 2013-2014
Clinical Trials
- Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma
- Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma
- Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma
Publications & Presentations
PubMed
- Outcomes of adolescents and young adults with AML treated on pediatric vs adult protocols.Baher Krayem, Jeetayu Biswas, Andriy Derkach, Michael Rafizadeh, Jenna Ciervo
Blood Advances. 2026-09-08 - Survival by Race and Ethnicity in Children and Adolescents/Young Adults With Relapsed/Refractory Hodgkin Lymphoma: A Pooled Analysis of Children's Oncology Group Trials.Mallorie B Heneghan, Lindsay A Renfro, Yue Wu, Katia M Crisler, Erin Marcotte
Pediatric Blood & Cancer. 2026-09-01 - Complete remission of relapsed ATXN2L::JAK2 fusion positive anaplastic large cell lymphoma following ruxolitinib monotherapy in a child.Tal Cohen, Ting Zhou, Ukuemi Edema, Neeta Pandit-Taskar, Christopher Forlenza
NPJ Precision Oncology. 2026-02-14
Press Mentions
Article on Anti-Tumor Activity of PV-10 Against Relapsed and Refractory Neuroblastoma Published in OncoTargets and TherapyFebruary 19th, 2019
Paediatric Cancer Centre for GhanaMarch 30th, 2017
First International Paediatric Cancer Centre for GhanaMarch 29th, 2017
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
